<DOC>
	<DOCNO>NCT01356602</DOCNO>
	<brief_summary>This study assess safety efficacy canakinumab pre-filled syrinx comparison triamcinolone acetonide 40 mg canakinumab lyophilizate patient frequent flare acute gouty arthritis .</brief_summary>
	<brief_title>Safety Efficacy Canakinumab Prefilled Syringes Frequently Flaring Acute Gouty Arthritis Patients</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Gouty</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Inclusion criterion : 3 gout flare within last year Contraindication , intolerance lack efficacy NSAIDs and/or colchicine Body mass index less equal 45 kg/m2 Exclusion criterion : Use follow therapy ( within vary protocol define timeframes ) : corticosteroid , narcotic , topical ice/cold pack , chronic opiate treatment , NSAIDs ( aspirin ) , colchicine . Hemodialysis Live vaccine within 3 month first dose Donation loss 400 mL within 3 month first dose Gout bring factor chemotherapy , lead , transplant , etc . Presence acute inflammatory arthritis Rheumatoid Arthritis Any condition significant medical problem put patient unacceptable immunological risk receive type therapy HIV , Hepatitis , Tuberculosis infections/conditions Significant cardiovascular condition uncontrolled hypertension Significant medical disease uncontrolled diabetes , thyroid disease History malignancy organ system within past 5 year Women pregnant nursing Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Gout</keyword>
	<keyword>arthritis</keyword>
	<keyword>gout flare</keyword>
	<keyword>acute gout</keyword>
	<keyword>gouty</keyword>
	<keyword>rheumatic disease</keyword>
	<keyword>uric acid</keyword>
</DOC>